ArticleCancers2026

Risk of Malignancy with Immunosuppressive Drugs Used in Organ Transplants Compared to Those Used for Non-Transplant Indications.

Connor Haines et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.